FCE 20700
FCE 20700 is an orally active PGE2 analogue. FCE 20700 can prevent gastric mucosal damage and in inhibit gastric acid and pepsin secretion. FCE 20700 can be used for the research of gastrointestinal ulcer[1].
Product Specifications
CAS Number
[89648-76-0]
UNSPSC
12352211
Target
Prostaglandin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Inflammation/Immunology
Smiles
CCCC[C@H](C)[C@H](O)C#C[C@@H]1[C@H](C(CC1)=O)C/C=C\CCCC(OC)=O
Molecular Formula
C22H34O4
Molecular Weight
362.50
References & Citations
[1]Morini G, et al. Protective and antisecretory effects of the new PGE2 analogue, FCE 20700, and of 16,16 dimethyl PGE2 in pylorus-ligated rat. Pharmacol Res Commun. 1988 Nov;20 (11) :949-61.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
224149-01 50 µL
MEK2, phosphorylated (T394) (Dual Specificity Mitogen-Activated Protein Kinase Kinase 2, MAP Kinase Kinase 2, MAPKK 2, ERK Activator Kinase 2, MAPK/ERK Kinase 2, MEK 2, MAP2K2, MEK-2, MKK2, PRKMK2) discontinued
Ask
View Details 224149-02 100 µL
MEK2, phosphorylated (T394) (Dual Specificity Mitogen-Activated Protein Kinase Kinase 2, MAP Kinase Kinase 2, MAPKK 2, ERK Activator Kinase 2, MAPK/ERK Kinase 2, MEK 2, MAP2K2, MEK-2, MKK2, PRKMK2) discontinued
Ask
View Details 